Healthcare Business Management Association - HBMA
Leading the Business of Healthcare Login
Coronavirus Disease (COVID-19) Coronavirus Disease (COVID-19) - HBMA Healthcare Business Management Association

Coronavirus Disease (COVID-19) Update

Share
01/08/2021

HBMA COVID-19 Federal Response Update

White House and Federal Agencies

Centers for Disease Control and Prevention (CDC) Updates

Vaccine, Testing and Treatment

  • FDA Commissioner Stephen Hahn released a statement on following the authorized dosing schedules for COVID-19. The available data continue to support the use of two specified doses of each authorized vaccine at specified intervals. For the Pfizer-BioNTech COVID-19 vaccine, the interval is 21 days between the first and second dose. And for the Moderna COVID-19 vaccine, the interval is 28 days between the first and second dose.
    • Operation Warp Speed (OWS) Director Dr. Moncef Slaoui said government advisors were considering if patients could receive lower doses of the vaccine until vaccine supply improves.
  • A new study shows that Moderna’s vaccine was 94.1% efficacious in preventing symptomatic COVID-19. The vaccine also demonstrated efficacy in preventing severe COVID-19.
  • HHS Secretary Azar says states should expand the people who they offer the vaccine to in order to avoid wasting vaccines.
  • HHS is accelerating its efforts to distribute vaccines through pharmacies.
  • NIAID Director Dr. Anthony Fauci believes the U.S. will soon be able to vaccinate 1 million people a day.
  • U.S. Surgeon General Jerome Adams says states should not let their vaccine priority plans slow vaccinations.
  • HHS Secretary Alex Azar, Dr. Moncef Slaoui, and General Gustave Perna held a briefing to share updates on Operation Warp Speed and the COVID-19 vaccines.